Pim Bouwmans (P.)
MD and clinical epidemiologist who gained experience studying the impact of the COVID-19 pandemic on patients with end-stage kidney disease. After his PhD, he started studying the timely introduction of palliative care in dialysis patients who are non-waitlisted for kidney transplantation, including qualitative and quantitative studies, and using patient-reported outcome measures (PROMs), longitudinal data analysis, registration-based data, and pharmaco-epidemiological methods.
Expertises
Clinical nephro-epidemiology with focus on longitudinal analysis of registry-based data, patient-reported outcome measures (PROMs), qualitative research and pharmaco-epidemiology.
Career history
2025 - present: Scientific researcher at Erasmus Medical Center, department of Internal Medicine, division of Nephrology and Transplantation
2025 - present: Affiliated researcher, Karolinska Institue, department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
2025: Master of Science in Epidemiology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
2024–2025: Visiting PhD student, Karolinska Institute, Medical Epidemiology and Biostatistics, Stockholm, Sweden
2022–2023: Scientific Committee Member Dutch Nephrology Days
2021–2025: PhD student Maastricht University, FHML, department of Internal Medicine, division of Nephrology, CARIM, Maastricht, The Netherlands
2021–2024: Board Member Platform Researchers Nephrology, Dutch Federation of Nephrology
2021–2024: Junior Doctor (on-call), Nursing Home Care, Gericall, The Hague, Netherlands
2019–2020: Junior Doctor, Horacio Oduber Hospital, department of Surgery, Oranjestad, Aruba
2018–2019 and 2020-2021: Junior Doctor, Catharina Hospital Eindhoven, department of Internal Medicine, Eindhoven, The Netherlands
2018: Master of Medicine, Katholieke Universiteit Leuven, Leuven, Belgium